Dating for cancer patients uk


“It is completely unacceptable that, in 2015, this inflexible system is blocking access to life-extending treatments, like Kadcyla.

Treatments that could give people valuable extra time with their loved ones, and help them continue to contribute to society for many months or even years.


We are asking Aviva for £10,000 to help us fund next year's Shine Connect.Voting is simple, all we need you to do is to follow the link and vote for Shine - it's a simple as that!Breast cancer charities said they were particularly concerned about Kadcyla, currently prescribed to around 800 women a year, which has been shown to extend life by an average of six months, with fewer side effectives than any alternatives.Samia al Qadhi, Chief Executive at Breast Cancer Care, said: “This devastating decision will mean shattered hopes for thousands of women who could have been helped by these drugs.

Make a difference for young adults living with Cancer.We are taking part in the Aviva community fund project again!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>